tbuckley/cabot-search huggingface dataset:
Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care?
Authors: Marie-Luz Villa
Journal: Annals of Internal Medicine (2009)

Letters15 September 2009Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care?Marie-Luz Villa, MDMarie-Luz Villa, MDFrom the University of Washington School of Medicine, Seattle, WA 98104.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-151-6-200909150-00011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Although Katz and colleagues' suggestion (1) is well intentioned, making skilled-nursing facility (SNF) practice a specialty might impede entry of practitioners into long-term care, which could be a big tactical error. I witness fine practitioners start to attend residents of SNFs, then become quite attached to this practice setting. They ask questions, become informed, and then do an excellent job. The level of mentoring matters, as does the emphasis placed on excellent care. Lack of exposure to SNF practice implicates training programs as a cause of long-term care practitioner scarcity. Paperwork involved in providing care to SNF ...References1. Katz PR, Karuza J, Intrator O, Mor V. Nursing home physician specialists: a response to the workforce crisis in long-term care. Ann Intern Med. 2009;150:411-3. [PMID: 19293074] LinkGoogle Scholar2. American Academy of Home Care Physicians. Independence at Home Act Introduced! Accessed at www.aahcp.org/iahpr.pdf on 5 August 2009. Google Scholar Author, Article, and Disclosure InformationAffiliations: From the University of Washington School of Medicine, Seattle, WA 98104.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoNursing Home Physician Specialists: A Response to the Workforce Crisis in Long-Term Care Paul R. Katz , Jurgis Karuza , Orna Intrator , and Vincent Mor Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care? Heidi K. White , Gwendolen Buhr , Jose Gonzalez , and Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care? Leslie S. Libow and Gisele Wolf-Klein Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care? William B. Freedberg Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care? Paul R. Katz , Jurgis Karuza , and Vincent Mor Would a Nursing Home Physician Specialty Resolve the Workforce Crisis in Long-Term Care? Cheryl L. Phillips Metrics 15 September 2009Volume 151, Issue 6Page: 429-430KeywordsConflicts of interestGeriatricsHealth careHealth care qualityHealth care quality assessmentLong-term careNursing homesPatient advocacy ePublished: 15 September 2009 Issue Published: 15 September 2009 CopyrightCopyright © 2009 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Regionalization of cardiac surgery in the United States and Canada. Geographic access, choice, and outcomes
Authors: K. Grumbach
Journal: JAMA (1995)

<h3>Objective.</h3> —To determine how regionalization of facilities for coronary artery bypass surgery (CABS) affects geographic access to CABS and surgical outcomes. <h3>Design.</h3> —Computerized hospital discharge records were used to measure hospital CABS volume and in-hospital post-CABS mortality rates. Relationships between surgical volume and age- and sex-adjusted mortality rates were compared using χ<sup>2</sup>tests. Small-area analysis of the association between CABS rates and distances to nearest CABS hospital was performed using multivariate linear regression methods. <h3>Setting.</h3> —All nonfederal hospitals in New York, California, Ontario, Manitoba, and British Columbia. <h3>Patients.</h3> —All adult residents of the five jurisdictions who underwent CABS in a hospital in their jurisdiction from 1987 through 1989. <h3>Results.</h3> —In New York and Canada, approximately 60% of all CABS operations took place in hospitals performing 500 or more CABS operations per year, compared with only 26% in California. The highest mortality rates were found among California hospitals performing fewer than 100 CABS operations per year (adjusted 14-day in-hospital mortality was 4.7% compared with 2.4% in high-volume California hospitals,<i>P</i>&lt;.001). The percentage of the population residing within 25 miles of a CABS hospital was 91% in California, 82% in New York, and less than 60% in Canada. Eliminating very low-volume (&lt;100 cases per year) CABS hospitals in California would increase travel distances to a CABS hospital only slightly for a small number of residents. The Canadian degree of regionalization was not associated with lower CABS rates within provinces for populations living at more remote distances from the nearest CABS hospital. <h3>Conclusion.</h3> —Regionalization of CABS facilities in New York and Canada largely avoids the problem of low-volume outlier hospitals with high postoperative mortality rates found in California. New York has avoided the redundancy of facilities that exists in California while still providing residents a geographically convenient selection of CABS hospitals. Stricter regionalization in Canada may leave residents with a more narrow choice of facilities, but does not disproportionately affect access to surgery for populations living at remote distances from CABS facilities. (<i>JAMA</i>. 1995;274:1282-1288)
Council on Pharmacy and Chemistry
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction for Euro Surveill. 2021;26(9)
Journal: Eurosurveillance (2021)

© This work is licensed under a Creative Commons Attribution 4.0 International License. Closure This is a corrected article applying to the following content: Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
Virtual Colonoscopy
Authors: Ronald M Summers, Ingmar Bitter, Nicholas Petrick
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Chemistry of Flesh Foods and Their Losses on Cooking. By R. A
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Drug Release
Authors: Irwin S. Eskwith
Journal: JAMA (1974)

<h3>To the Editor.—</h3> In a recent issue (229:689, 1974), Dr. Edward Freis complained about the slowness of the Food and Drug Administration (FDA) in releasing drugs for the treatment of hypertension. Several drugs have been used in England that are effective and yet have not been released here. As a result, he is critical of the federal agency. However, because of the FDA, there are no thalidomide babies in America, but there are quite a few in England. It might be better to be conservative and avoid catastrophe rather than to rush in too quickly. I think that on the whole, the FDA has done an excellent job in protecting Americans from toxic medication. It is well worth the extra wait that some people, at times, find so difficult.
Utility of bone marrow culture and biopsy in the diagnosis of disseminated infections in AIDS
Authors: Philip Keiser, Steven Rademacher, James W. Smith
Journal: American Journal of Hematology (1997)

Bone marrow examination (BME) has been used as a diagnostic test of last resort in HIV infected patients. Identifying factors that would increase the diagnostic yield of BME would be useful. A retrospective cohort study was done to determine the predictive value of BME for disseminated infection in 133 patients with HIV infection in a 4-year period at an active HIV clinical center. Thirty-two percent of the cases had evidence of a disseminated infection on BME but only 10% of cases had a diagnosis made exclusively by BME. Multivariate analysis demonstrated that a positive result was more likely in those patients with fewer than 50 CD4 cells/mm3 and those with a hematocrit of less than 25% (P < 0.01). BME can be a useful, low-risk diagnostic procedure in selected patients with HIV infection who are ill with a low CD4 count and/or have a hematocrit less than 25%. A diagnosis can usually be made by other means, suggesting that this test should be limited to those in whom other diagnostic modalities have been exhausted. Am. J. Hematol. 56:1–4, 1997. © 1997 Wiley-Liss, Inc.
Carcinoma in a mediastinal fifth parathyroid gland
Authors: D. J. Kastan
Journal: JAMA (1987)

COMMONLY four parathyroid glands are located in the neck.<sup>1,2</sup>The incidence of a fifth supernumery parathyroid gland has been reported to be between 2% and 6%.<sup>1,2</sup>Most reports of a hyperfunctioning supernumery parathyroid gland have been adenomas.<sup>3-5</sup>There have been only a few reports of parathyroid gland carcinoma occurring outside of the cervical region,<sup>6-9</sup>none of which were in a supernumery parathyroid gland. We believe this is the first report of a carcinoma occurring in a supernumery parathyroid gland. The patient is free of recurrence seven years after surgical excision. <h3>Report of a Case</h3> A 57-year-old woman was seen in the emergency department with a sprained ankle. Roentgenograms of the ankle revealed no evidence of skeletal trauma, but because of marked osteopenia, testing for serum calcium levels was performed, with values of greater than 15 mg/dL (&gt;3.74 mmol/L). The patient's detailed history was normal, aside from
Intracellular pH and intrinsic H buffering capacity in normal and hypertrophied right ventricle of ferret heart
Authors: E DO, D ELLIS, J NOIREAUD
Journal: Cardiovascular Research (1996)

To answer the questions: (a) What is the effect of hypertrophy on the intracellular pH (pHi) and buffering power of cardiac muscle, and (b) How does hypertrophy affect the ability of cardiac muscle to recover from intracellular acidosis induced by hypoxia.In nominally HCO3(-)-free, HEPES-buffered Tyrode solution (35 degrees C), pHi and the intrinsic buffering power (beta i, measured in the presence of amiloride) was investigated using pH-sensitive microelectrodes.beta i was similar in both preparations (25 mM/pH unit at pHi 7.04). beta i was inversely related to pHi but the relationship was not significantly modified by hypertrophy. In the absence of amiloride, the time constant of pHi recovery (tau r) on removal of NH+4, was similar in normal (4.0 +/- 0.2 min, n = 5) and in hypertrophied muscles (4.3 +/- 0.3 min, n = 4; n.s.). In both preparations, net acid extrusion (JH) was similarly increased at lower values of pHi. Lowering temperature from 35 degrees to 22 degrees caused an alkalinization (0.15 pH units) of pHi. At 22 degrees C the mean values of pHi, beta i, tau r and JH were similar in normal and in hypertrophied muscles. At both temperatures and in both groups of preparations, recovery of pHi following hypoxia is approximately exponential. The time constant of recovery of pHi following hypoxia (tau rh) at 22 degrees C was not significantly different in hypertrophied muscles (7.2 +/- 0.9 min, n = 8) compared to controls (10.6 +/- 1.8 min, n = 13). However, at 35 degrees C, there was a significant difference in the mean values of tau rh which was smaller for hypertrophied muscles (3.9 +/- 0.3 min, n = 7) than for normal (7.1 +/- 1.1 min, n = 4, P < 0.005). For pHi 6.8-7.0, net acid extrusion in hypertrophied preparations was increased by a factor of 4 compared to normal.The intracellular buffering capacity and the pHi regulating capacity via Na+/H+ exchange are not significantly modified by right ventricular hypertrophy in ferret heart. The faster pHi recovery from hypoxia-induced acidification can be interpreted in terms of the role of lactate efflux in pHi control. The possible role of energy compartmentalization, its influence on the Na+ gradient and thus on pHi control after hypoxia, is discussed.
Experimental Approach to the Determination of Pulmonary Carcinogenic Influences of Shale Oil Effluents
Authors: L. D. Palekar, D. L. Coffin
Journal: Environmental Health Perspectives (1979)

Oil derived from oil shale deposits is known to contain many organic complexes. The formation of carcinogenic hydrocarbons is temperature-dependent and is associated with retorting of the oil. Furthermore, oil shale is a rich source of inorganic elements such as the metals. Biological studies have demonstrated that concentrated extract of tars from combustion of shale oil are carcingenic to the skin of mice. The purpose of the current project is to evaluate the potential carcinogenic hazard from inhalation of retort and combustion effluents for man. These studies will be carried out in pathogen-free rats by intratracheal instillation with and without added factors such supplemental particles and known carcinogens as interactants.
MEDICAL ILLUSTRATION
Authors: MAX BRODEL
Journal: JAMA (1941)

This article is a brief attempt to describe the subject of medical illustrating as I see it, state the necessary qualifications of an applicant who wishes to devote his life to this work and tell of the opportunities for success in this field after he has systematically studied the subject and has mastered it in its essentials. It is agreed that a medical picture, correctly planned and accurately and artistically executed, is an integral part of the medical literature. It not only elucidates the text when needed but may in part even replace it. On the other hand, if not correctly planned or inaccurately drawn, or both, as often is the case, the picture is worse than useless and should be omitted. It is the business of the author of the book or article to eliminate a worthless picture. But it is also the duty of the illustrator to know
Mastectomy
Authors: Sarah Singer
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Galactose elimination test versus liver scores . Gastroenterology Clinic,St. Ivan Rilski University Hospital, Medical University, Sofia, Bulgaria
Journal: Hepatology (1995)

Simeprevir (SMV) is a once-daily (QD), oral hepatitis C virus (HCV) NS3/4A protease inhibitor approved for treatment of genotype (GT) 1 and GT4 infection. This Phase III, open-label, single-arm study (RESTORE; NCT01567735) evaluated efficacy/safety of SMV with peginterferon-α-2a/ribavirin (PR) in patients with chronic HCV GT4 infection.107 patients were included. Treatment-naïve (n = 35) and prior relapse patients (n = 22) received SMV 150 mg QD + PR (12 weeks), followed by PR alone (12 or 36 weeks, response-guided [HCV RNA <25 IU/ml detectable/undetectable at week 4 and <25 IU/ml undetectable at week 12]). Prior non-responders (partial, n = 10; null, n = 40) received SMV/PR (12 weeks), followed by PR for 36 weeks. The primary endpoint was sustained virologic response 12 weeks after end of treatment (SVR12).Median age: 49.0 years; 28.0% Black/African; 7.5% IL28B CC; 28.8% METAVIR F4. Overall, 65.4% (70/107) of patients achieved SVR12 (82.9% [29/35] treatment-naïve; 86.4% [19/22] prior relapsers; 60.0% [6/10] prior partial responders; 40.0% [16/40] prior null responders). In treatment-naïve and prior relapser patients fulfilling response-guided criteria for 24 weeks of treatment (88.6% [31/35] and 90.9% [20/22]), SVR12 rates were high: 93.5% [29/31] and 95.0% [19/20], respectively. Overall on-treatment failure and relapse rates were 23.4% (25/107) and 14.6% (12/82), respectively. Adverse events (AEs) were mainly grade 1/2; serious AEs were infrequent (4.7%) and considered unrelated to SMV.Efficacy and safety of SMV 150 mg QD for 12 weeks with PR in treatment-naïve or -experienced patients with chronic HCV GT4 infection were in line with previous reports for HCV GT1 infection.
Semen Quality and Reproductive Endocrine Function in Relation to Biomarkers of Lead, Cadmium, Zinc, and Copper in Men
Authors: Spomenka Telisman, Petar Cvitkovic, Jasna Jurasovic, Alica Pizent, Mirjana Gavella, Boris Rocic
Journal: Environmental Health Perspectives (2000)

Blood lead (BPb), activity of delta-aminolevulinic acid dehydratase (ALAD), erythrocyte protoporphyrin (EP), blood cadmium (BCd), serum zinc (SZn), seminal fluid zinc (SfZn), serum copper (SCu), and parameters of semen quality and of reproductive endocrine function were measured in 149 healthy male industrial workers 20-43 years of age. The group contained 98 subjects with slight to moderate occupational exposure to Pb and 51 reference subjects. All of the subjects lived in Zagreb, Croatia. Significant (p < 0.05) correlations of BPb, ALAD, and/or EP with reproductive parameters indicated a Pb-related decrease in sperm density, in counts of total, motile, and viable sperm, in the percentage and count of progressively motile sperm, in parameters of prostate secretory function (SfZn, acid phosphatase, and citric acid in seminal fluid), and an increase in abnormal sperm head morphology, serum testosterone, and estradiol. These associations were confirmed by results of multiple regression, which also showed significant (p < 0. 05) influence of BCd, SZn, SCu, smoking habits, alcohol consumption, or age on certain reproductive parameters. These effects were mainly of lower rank and intensity as compared to Pb-related reproductive effects, whereas BCd contributed to a decrease in sperm motility and an increase in abnormal sperm morphology and serum testosterone. No significant Pb- or Cd-related influence was found on levels of the lactate dehydrogenase isoenzyme LDH-C(4) and fructose in seminal fluid or on follicle-stimulating hormone, luteinizing hormone, and prolactin in serum. The seminal fluid concentrations of Pb (SfPb) and Cd (SfCd) were measured in 118 of the 149 subjects, and a highly significant (p < 0.0001) correlation was found between BPb and SfPb levels (r = 0.571) and between BCd and SfCd levels (r = 0.490). The overall study results indicate that even moderate exposures to Pb (BPb < 400 microg/L) and Cd (BCd < 10 microg/L) can significantly reduce human semen quality without conclusive evidence of impairment of male reproductive endocrine function.
Can we clinically measure infarction size?
Authors: R. Roberts
Journal: JAMA (1979)

SINCE the advent of the coronary care unit (CCU) in 1962, the in-hospital mortality of patients with acute myocardial infarction has been notably reduced, predominantly because of better management of ventricular arrhythmias. Despite adequate antiarrhythmic therapy, there remains a 15% to 25% acute mortality that is related primarily to pump failure, a major determinant of which is the extent of myocardial damage (infarct size). Postmortem studies have shown that patients dying of cardiogenic shock exhibit 40% or more destruction of the myocardium. Clearly, therapeutic efforts in the modern CCU must be directed toward reducing the extent of myocardial damage associated with myocardial infarction. Pioneering studies by Braunwald and others<sup>1</sup>suggested that the development of myocardial damage is a dynamic event that can be favorably altered, notably by decreasing the imbalance between myocardial oxygen supply and demand. This provided the impetus for an area of research, namely, protection of ischemic myocardium,